UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035341
Receipt number R000040260
Scientific Title Cardiopulmonary exercise test for high risk lung cancer surgery
Date of disclosure of the study information 2018/12/21
Last modified on 2020/12/22 17:01:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cardiopulmonary exercise test for high risk lung cancer surgery

Acronym

Cardiopulmonary exercise test for high risk lung cancer surgery

Scientific Title

Cardiopulmonary exercise test for high risk lung cancer surgery

Scientific Title:Acronym

Cardiopulmonary exercise test for high risk lung cancer surgery

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify the efficacy of cardiopulmonary exercise test for high risk lung cancer patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

relationship between CPET and perioperative complications

Key secondary outcomes

relationship between CPET and six minute walk test, respiratory function test and echocardiogram


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

ergometer

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Lung cancer
2 Pneumonectomy
3 ppo%FEV1<60% or ppo%DLCO<60%

Key exclusion criteria

1 Not appropriate for CPET

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Nagayasu

Organization

Nagasaki University Graduate School of Medicine

Division name

Surgical Oncology

Zip code

8528501

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7304

Email

nagayasu@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Takuro
Middle name
Last name Miyazaki

Organization

Nagasaki University Graduate School of Medicine

Division name

Surgical Oncology

Zip code

8528501

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7304

Homepage URL


Email

miyataku@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Graduate School of Medicine

Address

1-7-1 Sakamoto, Nagasaki, JAPAN

Tel

095-819-7304

Email

miyataku@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長崎大学病院(長崎県)


Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 01 Month 21 Day

Date of IRB

2019 Year 01 Month 22 Day

Anticipated trial start date

2019 Year 02 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 12 Month 21 Day

Last modified on

2020 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040260


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name